Advanced Search
Contact | Corporate | Help

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

Sponsors:
  • AlphaVax, Inc.
  • National Institute of Allergy and Infectious Diseases (NIAID)
Phases:
  • Phase I
IndicationsAcronym:
  • HIV Infections
Age Groups:
  • Adult
Gender:
Both
Names:
  • Biological: AVX101
Enrollment:
96

Additional information about NCT00097838.


SourceSolution © 2008-2012